药物设计精彩课件(英文).pdf

golden21c

Drug Discovery (758 k
http://www.kubinyi.de/dd-01.pdf

Serendipity and Rational Design (374 k
http://www.kubinyi.de/dd-02.pdf

Chemogenomics (1,453 k
http://www.kubinyi.de/dd-03.pdf

Ligand-Receptor Interactions (647 k
http://www.kubinyi.de/dd-04.pdf

Hydrogen Bonds and Biological Activities (359 k
http://www.kubinyi.de/dd-05.pdf

Chemical Similarity and Biological Activities (686 k
http://www.kubinyi.de/dd-06.pdf

Drug Metabolism (501 k
http://www.kubinyi.de/dd-07.pdf

Peptidomimetics and Prodrugs (294 k
http://www.kubinyi.de/dd-08.pdf

Combinatorial Chemistry Technology (147 k
http://www.kubinyi.de/dd-09.pdf

Combinatorial Chemistry in Drug Research (215 k
http://www.kubinyi.de/dd-10.pdf

QSAR Parameters (284 k
http://www.kubinyi.de/dd-11.pdf

QSAR - Hansch and Free Wilson Analyses (153 k
http://www.kubinyi.de/dd-12.pdf

Variable Selection and Model Validation (935 k
http://www.kubinyi.de/dd-13.pdf

Nonlinear QSAR and 3D QSAR (173 k
http://www.kubinyi.de/dd-14.pdf

QSAR Examples (138 k
http://www.kubinyi.de/dd-15.pdf

Structure-Based Ligand Design (782 k
http://www.kubinyi.de/dd-16.pdf

Computer-Aided Ligand Design (850 k
http://www.kubinyi.de/dd-17.pdf

Pharmacophore Analyses (486 k
http://www.kubinyi.de/dd-18.pdf

Virtual Screening (299 k
http://www.kubinyi.de/dd-19.pdf

Combinatorial and Fragment-Based Ligand Design (945 k
http://www.kubinyi.de/dd-20.pdf

Serine Proteases and their Inhibitors (371 k
http://www.kubinyi.de/dd-21.pdf

Thrombin Inhibitor Design (332 k
http://www.kubinyi.de/dd-22.pdf

Problems in Drug Design (1,043 k
http://www.kubinyi.de/dd-23.pdf

In Search for New Leads
http://www.kubinyi.de/paris-07-05.pdf

From Leads to Drugs
http://www.kubinyi.de/wien-06-05.pdf

Validation and Predictivity of QSAR Models
http://www.kubinyi.de/istanbul-2004-lecture.pdf